REFERENCES
1. Coronavirus (COVID-19). WHO. https://who.sprinklr.com/. Published
2020. Accessed May 25, 2020.
2. Clinical management of severe acute respiratory infection (SARI) when
COVID-19 disease is suspected. WHO.
file:///C:/Users/Admin/Downloads/WHO-2019-nCoV-clinical-2020.4-eng.pdf.
Published 2020. Accessed May 21, 2020.
3. CDC. Coronavirus Disease.
https://www.cdc.gov/coronavirus/2019-ncov/symptoms-testing/symptoms.html.
Published 2020. Accessed May 25, 2020.
4. Benvenuto, D., Giovanetti, M., Ciccozzi, A., Spoto, S., Angeletti,
S., & Ciccozzi M. The 2019‐new coronavirus epidemic: evidence for virus
evolution. J Med Virol . 2020;92(4):455-459.
5. Shereen, M. A., Khan, S., Kazmi, A., Bashir, N., & Siddique R.
COVID-19 infection: origin, transmission, and characteristics of human
coronaviruses. J Adv Res . 2020;24:91-98.
doi:https://doi.org/10.1016/j.jare.2020.03.005
6. World Health Organization Declares COVID-19 a “Pandemic.” Here’s
What That Means. Time . March 2020.
https://time.com/5791661/who-coronavirus-pandemic-declaration/.
7. Cunningham, A. C., Goh, H. P., & Koh D. Treatment of COVID-19: old
tricks for new challenges. Crit Care . 2020;24(91).
doi:https://doi.org/10.1186/s13054-020-2818-6
8. Tang, W., Cao, Z., Han, M., Wang, Z., Chen, J., Sun, W., … & Chen
W. Hydroxychloroquine in patients with mainly mild to moderate
coronavirus disease 2019: open label, randomised controlled trial.BMJ . 2020;369:m1849. doi:https://doi.org/10.1136/bmj.m1849
9. Mahévas, M., Tran, V. T., Roumier, M., Chabrol, A., Paule, R.,
Guillaud, C., … & Schlemmer F. Clinical efficacy of
hydroxychloroquine in patients with covid-19 pneumonia who require
oxygen: observational comparative study using routine care data.BMJ . 2020;369:m1844. doi:https://doi.org/10.1136/bmj.m1844
10. Coronavirus (COVID-19) Update: FDA Issues Emergency Use
Authorization for Potential COVID-19 Treatment. US-FDA.
https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-issues-emergency-use-authorization-potential-covid-19-treatment.
Published 2020. Accessed May 21, 2020.
11. Wang, Y., Zhang, D., Du, G., Du, R., Zhao, J., Jin, Y., … & Hu Y.
Remdesivir in adults with severe COVID-19: a randomised, double-blind,
placebo-controlled, multicentre trial. Lancet . 2020.
doi:https://doi.org/10.1016/S0140-6736(20)31022-9
12. Chen, L., Xiong, J., Bao, L., & Shi Y. Convalescent plasma as a
potential therapy for COVID-19. Lancet Infect Dis .
2020;20(4):398-400.
13. Recommendations for Investigational COVID-19 Convalescent Plasma.
US-FDA.
https://www.fda.gov/vaccines-blood-biologics/investigational-new-drug-ind-or-device-exemption-ide-process-cber/recommendations-investigational-covid-19-convalescent-plasma.
Published 2020. Accessed May 25, 2020.
14. Duan, K., Liu, B., Li, C., Zhang, H., Yu, T., Qu, J., … & Peng C.
Effectiveness of convalescent plasma therapy in severe COVID-19
patients. Proc Natl Acad Sci . 2020;117(17):9490-9496.
doi:https://doi.org/10.1073/pnas.2004168117
15. Casadevall, A., & Pirofski LA. The convalescent sera option for
containing COVID-19. J Clin Invest . 2020;130(4).
16. Liberati, A., Altman, D. G., Tetzlaff, J., Mulrow, C., Gøtzsche, P.
C., Ioannidis, J. P., … & Moher D. The PRISMA statement for reporting
systematic reviews and meta-analyses of studies that evaluate health
care interventions: explanation and elaboration. Ann Intern Med .
2009;151(4):W-65.
17. Ye, Mingxiang., Fu, Dian., Ren, Yi., Wang, Faxiang., Wang, Dong.,
Fang, Zhang., Xia, Xinyi., & Lv T. Treatment with convalescent plasma
for COVID‐19 patients in Wuhan, China. J Med Virol . 2020.
doi:https://doi.org/10.1002/jmv.25882
18. Anderson, J., Schauer, J., Bryant, S., & Graves CR. The use of
convalescent plasma therapy and remdesivir in the successful management
of a critically ill obstetric patient with novel coronavirus 2019
infection: A case report. Case Reports Women’s Heal .
2020;27:e00221. doi:https://doi.org/10.1016/j.crwh.2020.e00221
19. Shen, C., Wang, Z., Zhao, F., Yang, Y., Li, J., Yuan, J., … & Wei
J. Treatment of 5 critically ill patients with COVID-19 with
convalescent plasma. Jama . 2020;323(16):1582-1589.
doi:10.1001/jama.2020.4783
20. Zhang, B., Liu, S., Tan, T., Huang, W., Dong, Y., Chen, L., … &
Zou Y. Treatment with convalescent plasma for critically ill patients
with SARS-CoV-2 infection. Chest . 2020.
doi:https://doi.org/10.1016/j.chest.2020.03.039
21. Ahn JY, Sohn Y, Lee SH et al. Use of Convalescent Plasma Therapy in
Two COVID-19 Patients with Acute Respiratory Distress Syndrome in Korea.J Korean Med Sci . 2020;35(14). doi:10.3346/JKMS.2020.35.E149
22. Zeng, Q. L., Yu, Z. J., Gou, J. J., Li, G. M., Ma, S. H., Zhang, G.
F., … & Li C. Effect of convalescent plasma therapy on viral shedding
and survival in COVID-19 patients. J Infect Dis . 2020.
doi:https://doi.org/10.1093/infdis/jiaa228
23. Salazar, E., Perez, K. K., Ashraf, M., Chen, J., Castillo, B.,
Christensen, P. A., … & Subedi S. Treatment of COVID-19 Patients with
Convalescent Plasma in Houston, Texas. medRxiv . 2020.
doi:https://doi.org/10.1101/2020.05.08.20095471
24. Joyner, M., Wright, R. S., Fairweather, D., Senefeld, J., Bruno, K.,
Klassen, S., … & Rea R. Early Safety Indicators of COVID-19
Convalescent Plasma in 5,000 Patients. medRxiv . 2020.
doi:https://doi.org/10.1101/2020.05.12.20099879
25. Tan, L., Kang, X., Zhang, B., Zheng, S., Liu, B., Yu, T., … &
Miao H. A special case of COVID-19 with long duration of viral shedding
for 49 days. medRxiv . 2020.
doi:https://doi.org/10.1101/2020.03.22.20040071
26. Pei, S., Yuan, X., Zhang, Z. Z., Yao, R. R., Xie, Y., Shen, M. M.,
… & Yin M. Convalescent plasma to treat covid-19: Chinese strategy
and experiences. medRxiv . 2020.
doi:https://doi.org/10.1101/2020.04.07.20056440
27. Yang, X., Sui, Y., Liu, F., Kang, Z., Wu, S., Zhao, J., … & Zhang
Y. Clinical Characteristics and Convalescent Plasma Therapy in Severe
and Critically Ill COVID-19 Patients. Prepr with LANCET . 2020.
https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3576894.
28. ClinicalTrials.gov. NIH U.S. National Library of Medicine.
https://clinicaltrials.gov/ct2/results?term=covid+19+convalescent+plasma&Search=Search.
Published 2020. Accessed May 25, 2020.
29. Ko, J. H., Seok, H., Cho, S. Y., Ha, Y. E., Baek, J. Y., Kim, S. H.,
… & Cho D. Challenges of convalescent plasma infusion therapy in
Middle East respiratory coronavirus infection: a single centre
experience. Antivir Ther . 2018;23(7):617-622. doi:10.3851/imp3243
30. Zhang, L., Pang, R., Xue, X., Bao, J., Ye, S., Dai, Y., … & Yi Y.
Anti-SARS-CoV-2 virus antibody levels in convalescent plasma of six
donors who have recovered from COVID-19. Aging (Albany NY) .
2020;12(8):6536-6542. doi:10.18632/aging.103102